This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Cytosite Biopharma Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Mark A Castanares: Innovator in Granzyme B Imaging and Therapy
Introduction
Mark A Castanares is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biomedical research, particularly in the area of imaging and therapy related to Granzyme B. His innovative work has the potential to impact the treatment of various immunoregulatory abnormalities.
Latest Patents
Mark A Castanares holds a patent for "Granzyme B directed imaging and therapy - Compounds of Formula (I) and Formula (II)." This patent describes compounds capable of binding to Granzyme B, along with pharmaceutical compositions that utilize these compounds for imaging Granzyme B and treating immunoregulatory abnormalities. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Mark is currently associated with Cytosite Biopharma Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions that leverage his patented technology to improve patient outcomes.
Collaborations
Mark A Castanares collaborates with talented professionals in his field, including Kevin Michael Ruley and James Kronauge. These partnerships enhance the research and development process, fostering an environment of innovation and discovery.
Conclusion
Mark A Castanares exemplifies the spirit of innovation in the biomedical field, particularly through his work on Granzyme B imaging and therapy. His contributions are paving the way for advancements in treatment options for immunoregulatory conditions.